SIBO Testing on Ozempic/Mounjaro, with Dr. Mark Pimentel

This video delves into the complexities and challenges of diagnosing Small Intestinal Bacterial Overgrowth (SIBO) in individuals taking popular GLP-1/GIP medications like semaglutide and tirzepatide.
Key Discussion Points

• Breath Tests:
  • GLP-1 drugs are known to slow down the digestive system.
  • This slowed transit means that the lactulose or glucose used in breath tests may not move out of the stomach as expected.
  • Consequently, a breath test might show a "flat line," not because SIBO is absent, or there is hydrogen sulfide, but because the substrate is not reaching the small intestine for bacterial fermentation. 
• Aspiration Studies (Endoscopy):
  • Similarly, these medications cause the stomach to empty more slowly, meaning food remains in the stomach longer.
  • This hinders the ability to perform accurate aspiration studies, as food can contaminate the catheter used to collect samples, leading to unreliable results.
• Treatment Efficacy:
  • The slow gastric emptying also raises questions about the effectiveness of treatments like rifaximin when administered to patients on GLP-1/GIP drugs. It's unclear if the antibiotic will successfully leave the stomach or be properly absorbed in the small intestine, to treat SIBO.

Potential Approaches and Unanswered Questions

• Testing Timing: One colleague suggested testing on the morning before taking a dose, or basically, one week after starting the medication, since they are dosed once a week.
• Drug Discontinuation: Another idea proposed is to stop the GLP-1/GIP medication for one to two weeks before undergoing a SIBO test.
• Limited Evidence: While stopping for a minimum of one week is sometimes recommended for SIBO breath tests, there hasn't been enough systematic observation to confirm its effectiveness.

Conclusion
Diagnosing and treating SIBO in patients using GLP-1/GIP drugs presents significant question marks. The impact of these medications on gut function creates a complex scenario where standard diagnostic tools are unreliable.

Products mentioned
– GLP-1 medicines are Ozempic and Wegovy (Semaglutide)
– GLP-1 + GIP medicines are Mounjaro and Zepbound (Tirzepatide)